Dwilewicz-Trojaczek J, Sek S
Kliniki Hematologii AM w Warszawie.
Pol Tyg Lek. 1996 May;51(19-22):266-8.
Retrospective investigations were carried out in 50 patients with L-LP in clinical stage IV. All those patients died of this disease. The life time of the studied patients varied from 2 to 120 months and the median was 29 months. Advanced age, co-occurrence of anaemia and increased serum gammaglobulin level were found to be bad prognostic factors. No correlation was found between life time and tumour size, platelet number, lymphocyte count of blood and bone marrow.
对50例临床IV期的L-LP患者进行了回顾性研究。所有这些患者均死于该疾病。研究患者的生存期为2至120个月,中位数为29个月。发现高龄、贫血并存以及血清γ球蛋白水平升高是不良预后因素。未发现生存期与肿瘤大小、血小板数量、血液和骨髓淋巴细胞计数之间存在相关性。